Thymulin Research Overview (also known as Facteur Thymique Serique, FTS, Serum Thymic Factor)

What Is Thymulin?

Thymulin (formerly called Facteur Thymique Serique or FTS) is a nonapeptide — nine amino acids — produced and secreted exclusively by epithelial cells of the thymus gland. It is unique among thymic hormones in its absolute requirement for zinc: thymulin is biologically active only when complexed with zinc ions. Without zinc, the peptide circulates in an inactive form and cannot exert its immunological functions.

Role in T-Cell Biology

Thymulin's primary function is the induction of T-lymphocyte differentiation markers. It promotes the expression of T-cell surface antigens on immature thymocytes, enabling them to become mature, functional T-cells capable of mounting antigen-specific immune responses. It also modulates cytokine production, particularly suppressing pro-inflammatory cytokines while supporting regulatory T-cell activity — giving it an anti-inflammatory profile alongside its immunostimulatory role.

Age-Related Decline

Circulating thymulin levels peak in childhood and early adolescence, then decline progressively with thymic involution — falling dramatically after age 40 and becoming barely detectable in individuals over 60. This decline is considered a major contributor to immunosenescence: the progressive deterioration of immune function with aging. Restoring thymulin signaling is therefore of significant interest in aging and longevity research.

Therapeutic Research

Thymulin and synthetic analogs have been studied in models of autoimmune disease (including thyroiditis and lupus), chronic inflammation, and immune deficiency. Zinc co-administration is essential in research protocols because zinc deficiency renders any administered thymulin inactive.

Quick Reference

Research Indications

Research Protocols

As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.

Peptide Interactions

Reported Research Time Points

Safety Notes

Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.

Quality Indicators

Research Citations

• Interactions between zinc and thymulin
  Dardenne, M., Pleau, J.M., 1994, Metal-Based Drugs
• Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat
  Safieh-Garabedian, B., Poole, S., Allchorne, A., Kanaan, S., Saade, N., Bhutto, B., 2002, British Journal of Pharmacology
• A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin
  Safieh-Garabedian, B., Kanaan, S.A., Jalakhian, R.H., Poole, S., Jabbur, S.J., Saade, N.E., 2003, Neuroscience
• Immunomodulatory role of thymulin in lung diseases
  Savino, W., Dardenne, M., 2010, Annals of the New York Academy of Sciences
• Thymus hormones as prospective anti-inflammatory agents
  Lunin, S.M., Novoselova, E.G., 2010, Expert Opinion on Therapeutic Targets
• Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging
  Thomas-Vaslin, V., Cumberland, R., Goldrath, A.W., et al., 2020, Immunity & Ageing
• Physiology and therapeutic potential of the thymic peptide thymulin
  Reggiani PC, Schwerdt JI, Console GM, 2014, Curr Pharm Des
• Thymulin and the neuroendocrine system
  Goya RG, Brown OA, Pléau JM, 2004, Peptides
• The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin
  Reggiani PC, Morel GR, Cónsole GM, 2009, Ann N Y Acad Sci
• Thymus-derived hormonal and cellular control of cancer
  Savino W, Lepletier A, 2023, Front Endocrinol (Lausanne)
• Protective effect of exogenous peroxiredoxin 6 and thymic peptide thymulin on BBB conditions in an experimental model of multiple sclerosis
  Lunin SM, Novoselova EG, Glushkova OV, 2023, Arch Biochem Biophys